More than One Third of Louisiana Adults Have Prediabetes, Increased Risk for Serious Health Problems
January 29, 2018 12:30 ET
|
Louisiana Public Health Institute
New Orleans, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Across Louisiana, more than 35 percent of adults have prediabetes and are at an increased risk for serious health complications including kidney...
Solera Health Raises $18.3 Million in Series B Funding to Scale New Model for Chronic Disease Prevention and Management
July 12, 2017 10:00 ET
|
Solera Health
PHOENIX, July 12, 2017 (GLOBE NEWSWIRE) -- Solera Health, a provider of integrated chronic disease prevention services, announced today that the company has raised $18.3 million in Series B funding...
Solera Health Further Bolsters Executive Management Team with Appointment of Brian Esterly as Chief Operating Officer
June 28, 2017 10:00 ET
|
Solera Health
PHOENIX, June 28, 2017 (GLOBE NEWSWIRE) -- Solera Health, a preventive services benefits manager, announced today that it has further strengthened its executive management team with the strategic...
Study Shows Quantose IR(TM) Measures Insulin Sensitivity Better Than A1C Test for Prediabetes
March 18, 2015 16:24 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., March 18, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc. announced results from a study using samples from the long-term ACT NOW diabetes prevention study of prediabetic...
Newly Published Results Support Clinical Validity of Quantose IGT(TM) Diabetes Test
January 20, 2015 14:28 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 20, 2015 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced that results from a study of its Quantose IGT™ test were recently...
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
September 17, 2014 11:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...
Metabolon to Sponsor Study at Geisinger Medical Center With Quantose IR to Monitor Prediabetes Therapy
June 23, 2014 16:16 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test...
New Data on Metabolon's Prediabetes Test to be Featured in Two Poster Presentations at ADA Conference
June 12, 2014 12:22 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 12, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announces that two posters highlighting data from studies using its Quantose IGTTM...
Metabolon Announces Quantose IR Test Launched in Mexico to Help Prevent Type 2 Diabetes
June 04, 2014 15:34 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians...